NG2 antigen is a therapeutic target in human acute leukemia
Institute Josep Carreras
Filing date: 4 Aug, 2018
P14748PCT00
ICREA selects researchers based solely on their scientific achievements. However, excellent science often leads to the invention of new and amazing technologies and solutions. When that happens, ICREA fully supports the exploitation of these opportunities.
Our ICREA research professors are working in different Universities and Research Centres. On account of this, ownership of any intellectual or industrial property is always shared between ICREA and the host institution. To make negotiations as fast and conclusive as possible, host institutions are entitled to explore and engage in technology transfer activities on behalf of ICREA when opportunities arise. ICREA supports the exploitation efforts and offers advice throughout the process.
Please have a look at our current technologies and contact ICREA to learn more about them.
-
Life & Medical Sciences
NG2 antigen is a therapeutic target in human acute leukemia
Institute Josep Carreras
CLOSE -
Life & Medical Sciences
METHODS FOR IMPROVING RESPONSE TO ANTI-LIF ANTIBODY TREATMENT IN INDIVIDUALS WITH CANCER
CLOSE METHODS FOR IMPROVING RESPONSE TO ANTI-LIF ANTIBODY TREATMENT IN INDIVIDUALS WITH CANCER
Filing date: 18 Jun, 2018
-
Life & Medical Sciences
METHODS OF QUANTIFYING LIF AND USES THEREOF
CLOSE METHODS OF QUANTIFYING LIF AND USES THEREOF
Filing date: 18 Jun, 2018
-
Life & Medical Sciences
COMBINATION OF LIF INHIBITORS AND PLATINUM-BASED ANTINEOPLASTIC AGENTS FOR USE IN TREATING CANCER
CLOSE COMBINATION OF LIF INHIBITORS AND PLATINUM-BASED ANTINEOPLASTIC AGENTS FOR USE IN TREATING CANCER
Filing date: 18 Jun, 2018
-
Life & Medical Sciences
LIF DOSAGES
CLOSE LIF DOSAGES
Filing date: 14 May, 2018
-
Life & Medical Sciences
COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN TREATING CANCER
Mosaic Biomedicals, S.L.U., et al
CLOSE COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN TREATING CANCER
Mosaic Biomedicals, S.L.U., et al
Filing date: 12 Apr, 2018
18382248.5-1111
-
Experimental Sciences & Mathematics
Photocatalyst system and use thereof in a photocatalytic process
CLOSE Photocatalyst system and use thereof in a photocatalytic process
Filing date: 15 Nov, 2017
EP17382772
-
Engineering Sciences
ID0097-00 / Confidential
ICFO and ICREA
CLOSE ID0097-00 / Confidential
ICFO and ICREA
Filing date: 6 Nov, 2017
Licenced date: 24 Nov, 2017
PCT/ES2017/070734
-
Experimental Sciences & Mathematics
LAYERED ELECTROOSMOTIC STRUCTURE
Osmotex AG
CLOSE LAYERED ELECTROOSMOTIC STRUCTURE
A layered structure for pumping fluid by electroosmotic transport is provided. The layered structure comprising: a first layer, wherein the first layer is made from an ion perm selective material having openings therein that permit the fluid to flow therethrough, and wherein the openings in the first layer that permit the fluid to flow therethrough create a porosity of less than 10%; and a second layer, wherein the second layer is an electroosmotic layer. The layered structure having a net fluid flow direction that extends through the first layer and the second layer, wherein the layered structure has a region that permits fluid to flow in a direction that is non- parallel to a net fluid flow direction, and wherein the region is located between the first layer and the surface of the second layer that is furthest from the first layer. An electroosmodialysis apparatus may also be provided that comprises two layered structures.
Osmotex AG
Filing date: 8 Sep, 2017
WO/2018/046659
-
Life & Medical Sciences
Protein expression assays and methods
CRG
CLOSE Protein expression assays and methods
CRG
Filing date: 31 May, 2017
1708679.4
